Nacalai to Distribute TriLink Tools in Asia | GenomeWeb

NEW YORK (GenomeWeb News) – TriLink BioTechnologies said today that Nacalai USA will distribute TriLink's nucleic acid products in certain Asian countries.

Under the agreement, Nacalai will distribute TriLink's technologies in Japan, Singapore, South Korea, and Taiwan.

TriLink's product offerings include custom oligonucleotides, modified nucleoside triphosphates, and its CleanAmp PCR products for the diagnostic and OEM markets.

Nacalai USA is the San Diego-based subsidiary of Nacalai Tesque, of Kyoto, Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.